Field Trial - Biostache

Recent Articles..

To The Moon: Our Interview With ResearchSat
Recently, I had the chance to sit down and chat with ResearchSat’s founder/CEO RaviTeja Duggineni and their head of investor relations, Rahul Kundnani.
The Might of Mesoblast: How Perseverance Paid Off
Last year, Mesoblast Ltd had their therapeutic RYONCIL approved by the FDA. This article touches on the journey to get to this milestone.
Who needs a heartbeat? BiVACOR The New Artificial Titanium Heart
Heart disease remains one of the leading causes of death globally, BiVACOR may be the solution to this – a total artificial heart that utilises a single motor with MAGLEV technology to pump blood to the lungs and body.
The Micro Apocalypse: Antimicrobial Resistance
Antibiotics are arguably one of the most important biotechnological inventions of the last century. Access to effective antibiotic and antimicrobial drugs has saved countless lives, and allowed for advancements in healthcare, increasing the success of other medical interventions such as surgery and chemotherapy.
Here’s why last week’s stock market crash is a warning sign for Australia’s biotech sector
Investments in biotechnology are most impactful when made by those with deep pockets. The aim of the game is to make a return on investment, …
Read more "Here’s why last week’s stock market crash is a warning sign for Australia’s biotech sector"

Is GM Beer on the Horizon? Approved field trials sparks debate

by Ryan WallaceBiotechnology, GMOs May 4, 2024May 4, 2024No Comments

Will therebe GM beer in our foreseeable future? The success or failure of GM wheat and barley field trials will be the biggest indicator to this questions. But public perception of GMOs will be the ultimate decider.